Turn Therapeutics Inc.
TTRXDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 10, 2026
28dMarket Overview
Stock performance and key metrics
1 upcoming, 1 past
How TTRX's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
GX-03 | Phase 2 | Covid19 | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Turn Therapeutics Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Turn Therapeutics Inc.'s (TTRX) pipeline across Phase 2. Its lead program is GX-03 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Turn Therapeutics Inc.'s next FDA catalyst?→
Turn Therapeutics Inc.'s (TTRX) next tracked catalyst is a Earnings expected August 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TTRX biotech catalysts?→
Add TTRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Turn Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.